
Bavarian Nordic’s Jynneos highlights unmet need for mpox prevention in HIV patients
A recent study carried out at Charité Universitätsmedizin Berlin and published in The Lancet Infectious Diseases has shown that one dose of Bavarian Nordic’s Jynneos (smallpox and mpox vaccine, live, non-replicating) was overall 58% effective at preventing …